Levetiracetam Genericon

Levetiracetam, the active ingredient in Levetiracetam Genericon, is an anticonvulsant presented as an oral dosage form for oral use. It is indicated for the treatment of partial, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure control.

GNH USA supplies Levetiracetam Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to control seizures across several seizure types.

- Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes affecting the whole brain. - Myoclonic seizures: decreases sudden, brief muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Somnolence: increased sleepiness during the day. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare skin blistering condition. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe skin rash: widespread erythema or exfoliative dermatitis. - Blood disorders: leukopenia or thrombocytopenia. - Multi‑organ hypersensitivity: systemic inflammatory response affecting multiple organs.

Before initiating therapy, consider the following safety measures.

- Renal impairment: adjust dose based on creatinine clearance. - Pregnancy: category B1, use only if benefit outweighs risk. - Mood changes: monitor for depression or agitation. - Discontinuation: avoid abrupt cessation to prevent seizure worsening. - Hepatic impairment: use with caution in patients with liver disease. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with several medications, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, reducing levetiracetam levels. - Phenytoin: enzyme induction may lower drug exposure. - Phenobarbital: increases clearance, decreasing effectiveness. - Rifampicin: strong inducer leading to reduced plasma concentrations. - St. John’s wort: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations. - Oral contraceptives: reduced hormonal efficacy, consider alternative contraception. - Lamotrigine: potential additive CNS effects. - Topiramate: combined CNS depression risk. - Sedatives: enhanced drowsiness when used together.